PT Kimia Farma Persero Tbk (ISX:KAEF) Total Liabilities: Rp11,908,345 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:KAEF PT Kimia Farma Persero Tbk ISX:KAEF
56 GF Score
Price Rp454.00
GF Value Rp579.98
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Kimia Farma Persero Tbk Total Liabilities?

PT Kimia Farma Persero Tbk ISX:KAEF -0.87% 56 Total Liabilities is Rp11,908,345 Mil as of Jun. 2026. GuruFocus rates ISX:KAEF with a GF Score™ of 56/100 and a GF Value™ of Rp579.98 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Kimia Farma Persero Tbk's Total Liabilities for the quarter that ended in Jun. 2026 was Rp11,908,345 Mil.

PT Kimia Farma Persero Tbk's quarterly Total Liabilities increased from Dec. 2025 (Rp11,447,529.12 Mil) to Mar. 2026 (Rp11,499,584.46 Mil) and increased from Mar. 2026 (Rp11,499,584.46 Mil) to Jun. 2026 (Rp11,908,345.42 Mil).

PT Kimia Farma Persero Tbk's annual Total Liabilities declined from Dec. 2023 (Rp11,852,459.11 Mil) to Dec. 2024 (Rp11,499,735.45 Mil) and declined from Dec. 2024 (Rp11,499,735.45 Mil) to Dec. 2025 (Rp11,447,529.12 Mil).


PT Kimia Farma Persero Tbk Total Liabilities Historical Data

* Premium members only.

The historical data trend for PT Kimia Farma Persero Tbk's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Persero Tbk Total Liabilities Chart

PT Kimia Farma Persero Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,339,676.87 11,794,566.83 11,852,459.11 11,499,735.45 11,447,529.12

PT Kimia Farma Persero Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,680,076.99 11,716,246.57 11,447,529.12 11,499,584.46 11,908,345.42
ISX:KAEF
56GF Score
PT Kimia Farma Persero Tbk ISX:KAEF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Kimia Farma Persero Tbk Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PT Kimia Farma Persero Tbk's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7060554.489+(3432114.285+67504.31
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+887356.033+0)
=11,447,529

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=14183178.39-2735649.273
=11,447,529

PT Kimia Farma Persero Tbk's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4610372.087+(6410416.854+67504.309999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+820052.166+0)
=11,908,345

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=14698071.465-2789726.048
=11,908,345

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of Rp11,908,345 Mil mean?
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Total Liabilities of Rp11,908,345 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Kimia Farma Persero Tbk and its competitors.
Is PT Kimia Farma Persero Tbk's Total Liabilities too high?
PT Kimia Farma Persero Tbk's current Total Liabilities is Rp11,908,345 Mil. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Total Liabilities compare to MCK and COR?
PT Kimia Farma Persero Tbk's Total Liabilities of Rp11,908,345 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Kimia Farma Persero Tbk and its competitors. PT Kimia Farma Persero Tbk's current Total Liabilities is Rp11,908,345 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.98, compared to a current price of Rp454.00 — trading 21.7% below its estimated fair value. The current Total Liabilities is Rp11,908,345 Mil. PT Kimia Farma Persero Tbk's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Total Liabilities is Rp11,908,345 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued. The current stock price of Rp454.00 is trading 21.7% below its estimated GF Value™ of Rp579.98. GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.

Key valuation signals for ISX:KAEF:

  • Total Liabilities: Rp11,908,345 Mil
  • GF Value™: Rp579.98 vs. price of Rp454.00 (21.7% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Kimia Farma Persero Tbk Business Description

Address Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
56GF Score

Get the complete analysis for ISX:KAEF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp454.00
Price
Rp579.98
GF Value